|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 740676-740725 of 2348406 (46969 Page(s) Totally)
<< < 14809 14810 14811 14812 14813 14814 14815 14816 14817 14818 > >>
View [10|25|50] records per page
| 輔英科技大學 |
2016-03-14 |
Safe Sexual behaviors Intention with relationship partners among Adolescents–The Construction on Extended Theory of Planned Behavior
|
曾櫻花 |
| 國立成功大學 |
2006-09 |
Safe zone in isolation rooms
|
Kao, P. H.; Yang, Ruey-Jen |
| 國立成功大學 |
2022 |
Safe Zones for Percutaneous Carpal Tunnel Release
|
Wu, P.-T.;Chern, T.-C.;Wu, T.-T.;Shao, C.-J.;Wu, K.-C.;Kuo, L.-C.;Jou, I.-M. |
| 國立臺灣科技大學 |
2009-11-02 |
Safe-Commutation Strategy for Controlled Rectifier Operation Using Single-Phase Matrix Converter
|
S.Z.Mohammad Noor;R. Baharom;M.K.Hamzah;N.R.Hamzah |
| 朝陽科技大學 |
2016-05-31 |
Safe-Malaria - 瘧疾醫療整合包
|
陳宇薇 |
| 臺大學術典藏 |
2020-05-04T07:56:26Z |
SafeChain: Securing Trigger-Action Programming from Attack Chains
|
Hsu, K.-H.;Chiang, Y.-H.;Hsiao, H.-C.; Hsu, K.-H.; Chiang, Y.-H.; Hsiao, H.-C.; HSU-CHUN HSIAO |
| 國立政治大學 |
2008 |
Safeguard Gaps and their Managerial Issues
|
Tsaih, Rua-Huan ; Lin, Wan-Ying ; Chen, Ada; 蔡瑞煌;林宛瑩; |
| 東海大學 |
2008 |
Safeguard Intranet using embedded and distributed firewall system
|
Lin, Chu-Hsing, Jung-Chun Liu, Chien-Ting Kuo, Mei-Chun Chou and Tsung-Che Yang; 林祝興 |
| 東海大學 |
2009-03 |
Safeguard Intranet Using Embedded and Distributed Firewall System
|
林祝興; Lin, Chu-Hsing；Liu, Jung-Chun；Kuo, Chien-Ting；Chou, Mei-Chun；Yang, Tsung-Che |
| 東海大學 |
20081213-- |
Safeguard intranet using embedded and distributed firewall system
|
Lin, C.-H., Liu, J.-C., Kuo, C.-T., Chou, M.-C., Yang, T.-C. |
| 東海大學 |
2008-12-13 |
Safeguard intranet using embedded and distributed firewall system
|
Lin, C.-H., Liu, J.-C., Kuo, C.-T., Chou, M.-C., Yang, T.-C. |
| 中國文化大學 |
2007 |
Safeguardibg Taiwan's globally significant biodviersity : strengthing the domestic legal framework and particioating in the global biodviersity governaces system as an ecological entity
|
鄭欽哲 |
| 臺北醫學大學 |
2006 |
Safeguarding clinical software – A managerial case study about project management and oversight
|
Thomas Wetter |
| 臺北醫學大學 |
2006 |
Safeguarding clinical software – A managerial case study about project management and oversight
|
Thomas Wetter |
| 東海大學 |
2007-12 |
Safeguarding Investments and Creation of Transaction Value in Asymmetric International Subcontracting Relationships: The Role of Relationship Learning and Relational Capital
|
Chang, Kuo-Hsiung; Donald, F.Gotcher |
| 臺大學術典藏 |
2022-09-21T08:16:44Z |
Safeguarding medication use through interprofessional collaboration: Example of inpatient medication management and use
|
Yu H.-C.; Chen Y.-J.; Wu R.-S.; YUNN-FANG HO |
| 中國文化大學 |
2007 |
Safeguarding Taiwan's Globally Significant Biodviersty : Strengthening the Domestic Legal Framework and Participating in the Global biodiversity Governace System as an Ecological Entity
|
鄭欽哲 |
| 東海大學 |
2008 |
Safeguarding Taiwan’s national border: international pedophiles, mainland brides, and homosexual fraud husbands
|
Antonia Chao; 趙彥寧 |
| 東海大學 |
2008 |
Safeguarding Taiwan’s national border: international pedophiles, mainland brides, and homosexual fraud husbands.
|
Antonia Chao (趙彥寧) |
| 臺大學術典藏 |
2017 |
SaFePlay: A lightweight portable sensing system to estimate knee adduction moment
|
Wei, S.-Y. and Lo, Y.-P. and Lin, C.-Y. and Lin, T.-Y. and Chou, Y.-Y. and Huang, J.-T. and Yang, R.-S. and Hung, Y.-P.; RONG-SEN YANG |
| 臺大學術典藏 |
2021-05-31T02:56:55Z |
SaFePlay: A lightweight portable sensing system to estimate knee adduction moment
|
Wei S.-Y.;Lo Y.-P.;Lin C.-Y.;Lin T.-Y.;Chou Y.-Y.;Huang J.-T.;Rong-Sen Yang;Hung Y.-P.; Wei S.-Y.; Lo Y.-P.; Lin C.-Y.; Lin T.-Y.; Chou Y.-Y.; Huang J.-T.; RONG-SEN YANG; Hung Y.-P. |
| 臺大學術典藏 |
2021-03-19T01:31:35Z |
Safer way for vertebroplasty under fluid mechanics theory.
|
HSUAN-YU CHEN; Yen-Po Lin; Han Ying Wang; Feng Huei Lin; Po-Quang Chen; Ding-cheng Chan; Tze Hong Wong; Ming-Hsiao Hu |
| 國立成功大學 |
2023 |
Safest-path planning approach for indoor fire evacuation
|
Shih, G.-R.;Tsai, P.-H. |
| 嘉南藥理大學 |
2009 |
Safety & Security in Tourism
|
EBSCO-HTC |
| 國家衛生研究院 |
2016-06 |
Safety across subgroups in NAPOLI-1: A phase 3 study of nal-IRI (MM-398) +/- 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Chen, LT;Siveke, J;Wang-Gillam, A;Hubner, R;Pant, S;Dragovich, T;Chung, V;Chang, D;Ross, P;Cooray, P;Tebbutt, N;Franke, F;Belanger, B;Dhindsa, N;de Jong, F;Mamlouk, K;Von Hoff, D |
| 國立臺灣大學 |
2012 |
Safety Analysis of FOLFOX4 Treatment in Colorectal Cancer Patients: A Comparison Between Two Asian Studies and Four Western Studies
|
Sugihara, Kenichi; Ohtsu, Atsushi; Shimada, Yasuhiro; Mizunuma, Nobuyuki; Lee, Po-Huang; de Gramont, Aimery; Goldberg, Richard M.; Rothenberg, Mace L.; Andre, Thierry; Brienza, Silvano; Gomi, Katsushige; 李伯皇 |
| 臺大學術典藏 |
2018-09-10T09:13:29Z |
Safety analysis of FOLFOX4 treatment in colorectal cancer patients: A comparison between two Asian studies and four western studies
|
Sugihara, K. and Ohtsu, A. and Shimada, Y. and Mizunuma, N. and Lee, P.-H. and De Gramont, A. and Goldberg, R.M. and Rothenberg, M.L. and André, T. and Brienza, S. and Gomi, K.; PO-HUANG LEE |
| 臺大學術典藏 |
2020-11-19T03:19:35Z |
Safety analysis of FOLFOX4 treatment in colorectal cancer patients: A comparison between two Asian studies and four western studies
|
Sugihara K.;Ohtsu A.;Shimada Y.;Mizunuma N.;Po-Huang Lee;De Gramont A.;Goldberg R.M.;Rothenberg M.L.;Andr? T.;Brienza S.;Gomi K.; Sugihara K.; Ohtsu A.; Shimada Y.; Mizunuma N.; PO-HUANG LEE; De Gramont A.; Goldberg R.M.; Rothenberg M.L.; Andr? T.; Brienza S.; Gomi K. |
| 淡江大學 |
2008-12 |
Safety Analysis of Level Crossing Surveillance Systems Using Fuzzy Petri Nets
|
Tao, Chi-chung; Lin,Tsung-chin |
| 臺大學術典藏 |
2022-09-06T08:33:56Z |
Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan
|
Sheng, Wang-Huei; Wang, Chung-Cheng; Chu, Ching-Chi; Lin, Yueh-Juh; SUI-YUAN CHANG; Ieong, Si-Man; Chang, Shan-Chwen |
| 臺大學術典藏 |
2022-09-15T01:08:45Z |
Safety and Antitumor Activity of a-PD-L1 Antibody as Monotherapy or in Combination witha-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors
|
Hollebecque A.; Chung H.C.; Miguel M.J.D.; Italiano A.; MacHiels J.-P.; Chia-Chi Lin; Dhani N.C.; Peeters M.; Moreno V.; Su W.-C.; Chow K.H.; Galvao V.R.; Carlse M.; Yu D.; Szpurka A.M.; Zhao Y.; Schmidt S.L.; Gandhi L.; Xu X.; Bang Y.-J. |
| 國立成功大學 |
2021 |
Safety and Antitumor Activity of a-PD-L1 Antibody as Monotherapy or in Combination witha-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors
|
Hollebecque, A.;Chung, H.C.;Miguel, Miguel M.J.D.;Italiano, A.;MacHiels, J.-P.;Lin, C.-C.;Dhani, N.C.;Peeters, M.;Moreno, V.;Su, W.-C.;Chow, K.H.;Galvao, V.R.;Carlse, M.;Yu, D.;Szpurka, A.M.;Zhao, Y.;Schmidt, Schmidt S.L.;Gandhi, L.;Xu, Xu X.;Bang, Y.-J. |
| 臺大學術典藏 |
2022-08-19T00:20:40Z |
Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: Results of the KEYnote-028 study
|
Hansen A.R.; Cheng J.D.; Thanigaimani P.; Saraf S.; CHIUN HSU; Lee S.-H.; Ejadi S.; Even C.; Cohen R.B.; Le Tourneau C.; Mehnert J.M.; Algazi A.; Van Brummelen E.M.J. |
| 臺大學術典藏 |
2020-04-10T12:51:01Z |
Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: Results of the KEYNOTE-028 study
|
Chiun Hsu;Lee S.-H.;Ejadi S.;Even C.;Cohen R.B.;Le Tourneau C.;Mehnert J.M.;Algazi A.;Van Brummelen E.M.J.;Saraf S.;Thanigaimani P.;Cheng J.D.;Hansen A.R.; Chiun Hsu; Lee S.-H.; Ejadi S.; Even C.; Cohen R.B.; Le Tourneau C.; Mehnert J.M.; Algazi A.; Van Brummelen E.M.J.; Saraf S.; Thanigaimani P.; Cheng J.D.; Hansen A.R. |
| 臺大學術典藏 |
2020-05-25T07:35:07Z |
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer
|
Saraf S; Thanigaimani P; Cheng J.D; Keam B.; Mehnert J.M; Varga A; Brose M.S; Aggarwal R.R; Chia-Chi Lin; Prawira A; De Braud F; Tamura K; Doi T; Piha-Paul S.A; Gilbert J |
| 國立成功大學 |
2006-07 |
Safety and antiviral activity of pradefovir in patients with chronic hepatitis B virus infection: 48-week analysis of a phase 2 study
|
Lim, S. G.; Lee, K. S.; Chuang, W. L.; Hwang, S. G.; Cho, M.; Lai, M. Y.; Chao, Y. C.; Chang, Ting-Tsung; Han, K. H.; Lee, C. M.; Um, S. H.; Yeon, J. E.; Yang, S. S.; Teo, E. K.; Peng, C. Y.; Lin, H. H.; Yang, S. S.; Huo, T. I.; Nguyen, T.; Chen, T. Y.; Hu, K. Q.; Xu, Y.; Sullivan-Bolyai, J. Z. |
| 臺大學術典藏 |
2021-03-21T23:14:58Z |
Safety and clinical activity of a new anti-PD-L1 antibody as monotherapy or combined with targeted therapy in advanced solid tumors: The PACT phase Ia/Ib trial
|
Patnaik, Amita; Yap, Timothy A.; Chung, Hyun Cheol; de Miguel, Maria J.; Bang, Yung Jue; Chia-Chi Lin; Su, Wu Chou; Italiano, Antoine; Chow, Kay Hoong; Szpurka, Anna M.; Yu, Danni; Zhao, Yumin; Carlsen, Michelle; Schmidt, Shelly; Vangerow, Burkhard; Gandhi, Leena; Xu, Xiaojian; Bendell, Johanna |
| 臺大學術典藏 |
2022-09-15T01:08:50Z |
Safety and clinical activity of a new anti-PD-L1 antibody as monotherapy or combined with targeted therapy in advanced solid tumors: The PACT phase Ia/Ib trial
|
Patnaik A.; Yap T.A.; Chung H.C.; de Miguel M.J.; Bang Y.-J.; Chia-Chi Lin; Su W.-C.; Italiano A.; Chow K.H.; Szpurka A.M.; Yu D.; Zhao Y.; Carlsen M.; Schmidt S.; Vangerow B.; Gandhi L.; Xu X.; Bendell J. |
| 國立成功大學 |
2021 |
Safety and clinical activity of a new anti-PD-L1 antibody as monotherapy or combined with targeted therapy in advanced solid tumors: The PACT phase Ia/Ib trial
|
Patnaik, A.;Yap, T.A.;Chung, H.C.;de, Miguel M.J.;Bang, Y.-J.;Lin, C.-C.;Su, W.-C.;Italiano, A.;Chow, K.H.;Szpurka, A.M.;Yu, D.;Zhao, Y.;Carlsen, M.;Schmidt, Schmidt S.;Vangerow, B.;Gandhi, L.;Xu, Xu X.;Bendell, J. |
| 臺大學術典藏 |
2018-09-10T09:52:57Z |
Safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to prior etanercept
|
Wang, T.-S. and Tsai, T.-F.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:28:05Z |
Safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to prior etanercept
|
Wang T.-S.;Tsen-Fang Tsai; Wang T.-S.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-28T02:39:33Z |
Safety and Effectiveness of Hyaluronic Acid Fillers With Lidocaine for Full-Face Treatment in Asian Patients
|
Huang, She-Hung;Tsen-Fang Tsai; Huang, She-Hung; TSEN-FANG TSAI |
| 國立成功大學 |
2017 |
Safety and effectiveness of intravenous thrombolysis for acute ischemic stroke outside the coverage of National Health Insurance in Taiwan
|
Su, Y.-H.;Lin, H.-J.;Chen, Y.-W.;Tseng, M.-C.;Hsieh, Hsieh H.-C.;Chen, Chen C.-H.;Sung, Sung S.-F. |
| 國立成功大學 |
2021 |
Safety and effectiveness of new embolization microspheres SCBRM for intermediate-stage hepatocellular carcinoma: A feasibility study
|
Liu;Yi-Sheng;Lin;Xi-Zhang;Chen;Chiung-Yu;Chiu;Yen-Cheng;Kang;Jui-Wen;Tsai;Hung-Wen;Hung;Hui-Yu;Ho;Chi-Ming;Ou;Ming-Ching |
| 中國醫藥大學 |
2014-10 |
Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn’s Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study
|
(Chen-Wang Chang);(Shu-Chen Wei);周仁偉(Jen-Wei Chou);(Tzu-Chi Hsu);(Chiao-Hsiung Chuang);(Ching-Pin Lin);(Wen-Hung Hsu);(Hsu-Heng Yen);(Jen-Kou Lin);(Yi-Jen Fang);(Horng-Yuan Wang);(Hung-Hsin Lin);(Deng Cheng Wu);(Yen Hsuan Ni);(Cheng-Yi Wang);(Jau-Min Wong)* |
| 國立成功大學 |
2000-08 |
Safety and efficacy of Alprostadil Sterile Powder (S. Po.. CAVERJECT (R)) in diabetic patients with erectile dysfunction
|
Tsai, Yuh-Shyan; Lin, Johnny Shinn-Nan; Lin, Yung-Ming |
| 臺大學術典藏 |
2022-03-28T02:45:55Z |
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
|
Diaz-Manera J.; Kishnani P.S.; Kushlaf H.; Ladha S.; Mozaffar T.; Straub V.; Toscano A.; van der Ploeg A.T.; Berger K.I.; Clemens P.R.; YIN-HSIU CHIEN; Day J.W.; Illarioshkin S.; Roberts M.; Attarian S.; Borges J.L.; Bouhour F.; Choi Y.C.; Erdem-Ozdamar S.; Goker-Alpan O.; Kostera-Pruszczyk A.; Haack K.A.; Hug C.; Huynh-Ba O.; Johnson J.; Thibault N.; Zhou T.; Dimachkie M.M.; Schoser B.; Behin A.; Boentert M.; Carvalho G.; Chahin N.; Charrow J.; Deegan P.; Durmus Tekce H.; Duval F.; Genge A.; Gutmann L.; Henderson R.D.; Hennermann J.B.; Hiwot T.; Hughes D.; Karaa A.; Karam C.; Kautzky-Willer A.; Komaki H.; Laforet P.; Longo N.; Malinova V.; Mar? R.; Maxit C.; Mengel E.; Moggio M.G.; Moln?r M.J.; Mongini T.E.; Nadaj-Pakleza A.; Nascimento Osorio A.; Noury J.-B.; Oliveira A.S.B.; Parman Y.; Pena L.; Remiche G.; Sciacco M.; Shieh P.B.; Smith C.; Stulnig T.; Taithe F.; Tard C.; Tarnopolsky M.; Vorgerd M.; Whitley C.; Young P.; Alonso-P?rez J.; Altemus P.; Aub?-Nathier A.-C.; Avelar J.B.; Bailey C.; Bekircan-Kurt C.E.; Billy J.; Boschi S.; Brown K.E.; Carrera Garcia L.; Chase L.; Cirne H.; Danjoux L.; Davion J.-B.; DeArmey S.; Fedotova E.; Gandolfo E.; Grosz Z.; Guellec D.; Guettsches A.-K.; Guglieri M.; Hatcher E.; Helms S.; Hufgard-Leitner M.; Klyushnikov S.A.; Langton J.; Linkov? L.; Mavroudakis N.; Mazurov? S.; Mori M.; M?ller-Miny L.; Musumeci O.; Nance C.S.; Natera-de Benito D.; Neel R.; Niizawa G.A.; Noll L.; Ortega E.; Pasnoor M.; Pautot V.; Potulska-Chromik A.; Pugliese A.; Questienne C.; Ramos Lopes M.; Reyes-Leiva D.; Riedl M.; Rugiero M.F.; Salort-Campana E.; Sgobbi Souza P.V.; Sole G.; Solera L.; Souto Lopes S.; Specht S.; Statland J.; Swenson A.; Tan C.Y.; Tizon S.; van der Beek N.A.M.E.; van Kooten H.A.; Wencel M.; Wenninger S.; Zagnoli F.; COMET Investigator Group |
| 臺大學術典藏 |
2021-12-14T23:12:28Z |
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
|
Diaz-Manera, Jordi; Kishnani, Priya S.; Kushlaf, Hani; Ladha, Shafeeq; Mozaffar, Tahseen; Straub, Volker; Toscano, Antonio; van der Ploeg, Ans T.; Berger, Kenneth I.; Clemens, Paula R.; YIN-HSIU CHIEN; Day, John W.; Illarioshkin, Sergey; Roberts, Mark; Attarian, Shahram; Borges, Joao Lindolfo; Bouhour, Francoise; Choi, Young Chul; Erdem-Ozdamar, Sevim; Goker-Alpan, Ozlem; Kostera-Pruszczyk, Anna; Haack, Kristina An; Hug, Christopher; Huynh-Ba, Olivier; Johnson, Judith; Thibault, Nathan; Zhou, Tianyue; Dimachkie, Mazen M.; Schoser, Benedikt; Behin, Anthony; Boentert, Matthias; Carvalho, Gerson; Chahin, Nizar; Charrow, Joel; Deegan, Patrick; Durmus Tekce, Hacer; Duval, Fanny; Genge, Angela; Gutmann, Ludwig; Henderson, Robert D.; Hennermann, Julia B.; Hiwot, Tarekegn; Hughes, Derralynn; Karaa, Amel; Karam, Chafic; Kautzky-Willer, Alexandra; Komaki, Hirofumi; Laforet, Pascal; Longo, Nicola; Malinova, Vera; Maré, Ricardo; Maxit, Clarisa; Mengel, Eugen; Moggio, Maurizio Gualtiero; Molnár, Mária Judit; Mongini, Tiziana Enrica; Nadaj-Pakleza, Aleksandra; Nascimento Osorio, Andres; Noury, Jean Baptiste; Oliveira, Acary Souza Bulle; Parman, Yesim; Pena, Loren; Remiche, Gauthier; Sciacco, Monica; Shieh, Perry B.; Smith, Cheryl; Stulnig, Thomas; Taithe, Frederic; Tard, Céline; Tarnopolsky, Mark; Vorgerd, Matthias; Whitley, Chester; Young, Peter; Alonso-Pérez, Jorge; Altemus, Patricia; Aubé-Nathier, Anne Catherine; Avelar, Jennifer B.; Bailey, Carrie; Bekircan-Kurt, Can Ebru; Billy, Jenny; Boschi, Silvia; Brown, Kathryn E.; Carrera Garcia, Laura; Chase, Lauren; Cirne, Hamilton; Danjoux, Loïc; Davion, Jean Baptiste; DeArmey, Stephanie; Fedotova, Ekaterina; Gandolfo, Eve; Grosz, Zoltan; Guellec, Dewi; Guettsches, Anne Katrin; Guglieri, Michela; Hatcher, Erin; Helms, Sina; Hufgard-Leitner, Miriam; Klyushnikov, Sergey A.; Langton, Jacqui; Linková, Lenka |
| 臺大學術典藏 |
2018-09-10T03:23:08Z |
Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections
|
Fang, C.-T. and Chen, Y.-C. and Lin, S.-F. and Shau, W.-Y. and Liu, C.-J. and Sheng, W.-H. and Wang, J.-T. and Chang, S.-C.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2021-02-26T02:00:29Z |
Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections
|
Fang C.-T.;Chen Y.-C.;Lin S.-F.;Shau W.-Y.;Liu C.-J.;Wang-Huei Sheng;Wang J.-T.;Chang S.-C.; Fang C.-T.; Chen Y.-C.; Lin S.-F.; Shau W.-Y.; Liu C.-J.; WANG-HUEI SHENG; Wang J.-T.; Chang S.-C. |
Showing items 740676-740725 of 2348406 (46969 Page(s) Totally)
<< < 14809 14810 14811 14812 14813 14814 14815 14816 14817 14818 > >>
View [10|25|50] records per page
|
